Parenteral nutrition related hepato-biliary disease in adults

Applied Physiology, Nutrition and Metabolism

Volumn 32, Issue 4, 2007, Pages 646-654

  Raman, Maitreyi ^a   Allard, Johane P ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Cholestasis; Fatty liver; Home parenteral nutrition; Liver disease

Indexed keywords

ANTIINFECTIVE AGENT; URSODEOXYCHOLIC ACID;

ADULT; BILIARY TRACT DISEASE; CHOLESTASIS; FATTY LIVER; GALLSTONE; HEPATITIS; HUMAN; INTESTINE; LIVER DISEASE; LIVER TRANSPLANTATION; REVIEW; TOTAL PARENTERAL NUTRITION; TRANSPLANTATION;

ADULT; ANTI-BACTERIAL AGENTS; BILIARY TRACT DISEASES; CHOLESTASIS; FATTY LIVER; GALLSTONES; HEPATITIS; HUMANS; INTESTINES; LIVER DISEASES; LIVER TRANSPLANTATION; PARENTERAL NUTRITION, TOTAL; URSODEOXYCHOLIC ACID;

EID: 34848852298     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H07-056     Document Type: Review

References (77)

1. Ahern, D.A., and Mitchell, M.E. 1989. Liver function in protein energy malnutrition measured by cinnamic acid tolerance and benzoic acid tolerance: effect of carnitine supplementation. Br. J. Nutr. 61: 209-221. doi:10.1079/BJN19890110.
2. Alwayn, I.P., Gura, K., Nose, V., Zausche, B., Javid, P., Garza, J., et al. 2005. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr. Res. 57: 445-452. doi:10.1203/01.PDR.0000153672.43030.75.
3. Barbier, J., Gineste, D., Kraimps, J.L., Benand, P., Carretier, M., Beau, S., et al. 1992. Hepatobiliary complications of total parenteral nutrition. Chirurgie, 118: 47-53.
4. Beath, S.V., Needham, S.J., Kelly, D.A., Booth, I.W., Raafat, F., Buick, R.G., et al. 1997. Clinical features and prognosis of children assessed for isolated small bowel or combined small bowel and liver transplantation. J. Pediatr. Surg. 32: 459-461. doi:10.1016/S0022-3468(97)90606-0.
5. Beau, P., Labat-Labourdette, J., Ingrand, P., and Beauchant, M. 1994. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? J. Hepatol. 20: 240-244. doi:10.1016/S0168-8278(05)80064- 9.
6. Bellenger, J., Bellenger, S., Clement, L., Mandard, S., Diot, C., Poisson, J.P., et al. 2004. A new hypotensive polyunsaturated fatty acid dietary combination regulates oleic acid accumulation by suppression of stearoyl CoA desaturase 1 gene expression in the SHR model of genetic hypertension. FASEB J. 18: 773-775.
7. Bowyer, B.A., Fleming, C.R., Haymond, M.W., and Miles, J.M. 1989. L-carnitine: effect of intravenous administration on fuel homeostasis in normal subjects and home parenteral nutrition patients with low plasma carnitine concentrations. Am. J. Clin. Nutr. 49: 618-623.
8. Briones, E.R., and Iber, F.L. 1995. Liver and biliary tract changes and injury associated with total parenteral nutrition: pathogenesis and prevention. J. Am. Coll. Nutr. 14: 219-228.
9. Buchman, A.L., Ament, M.E., Sohel, M., Dubin, M., Jenden, D.J., Roch, M., et al. 2001. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo controlled trial. JPEN J. Parenter. Enteral Nutr. 25: 260-268.
10. Buchmiller, C.E., Kleiman-Wexler, R.L., Ephgrave, K.S., Booth, B., and Hensley, C.E., 2nd. 1993. Liver dysfunction and energy source: results of a randomized clinical trial. JPEN J. Parenter. Enteral Nutr. 17: 301-306.
11. Bueno, J., Ohwada, S., Kocoshis, S., Mazariegos, G.V., Dvorchik, I., Sigurdsson, L., et al. 1999. Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J. Pediatr. Surg. 34: 27-32. doi:10.1016/S0022-3468(99)90223-3.
12. Burke, D.J., Alverdy, J.C., Aoys, E., and Moss, G.S. 1989. Glutamine-supplemented total parenteral nutrition improves gut immune function. Arch. Surg. 124: 1396-1399.
13. Cai, W., Wu, J., Hong, L., Xu, Y., Tang, Q., and Shi, C. 2006. Oxidative injury and hepatocyte apoptosis in total parenteral nutrition-associated liver dysfunction. J. Pediatr. Surg. 41: 1663-1668. doi:10.1016/j.jpedsurg. 2006.05.067.
14. Campos, A.C., Oler, A., Meguid, M.M., and Chen, T.Y. 1990. Liver biochemical and histological changes with graded amounts of total parenteral nutrition. Arch. Surg. 125: 447-450.
15. Capron, J.P., Gineston, J.L., Herve, M.A., and Braillon, A. 1983. Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet, 1: 446-447.
16. Cavicchi, M., Beau, P., Crenn, P., Degott, C., and Messing, B. 2000. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann. Intern. Med. 132: 525-532.
17. Chan, S., McCowen, K.C., Bistrian, B.R., Thibault, A., Keane-Ellison, M., Forse, R.A., et al. 1999. Incidence, prognosis and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery, 126: 28-34. doi:10.1067/msy.1999.98925.
18. Chen, C.Y., Tsao, P.N., Chen, H.L., Chou, H.C., Hsieh, W.S., and Chang, M.H. 2004. Ursodoxycholic acid (UDCA) therapy in very-low birth weight infants with parenteral nutrition associated cholestasis. J. Pediatr. 145: 317-321.
19. Chessex, P., Lavoie, J., Laborie, S., and Rouleau, T. 2001. Parenteral multivitamin supplementation induces both oxidant and antioxidant responses in the liver of newborn Guinea pigs. J. Pediatr. Gastroenterol. Nutr. 32: 316-321. doi:10.1097/00005176-200103000-00016.
20. Clarke, P.J., Ball, M.J., and Kettlewell, M.G. 1991. Liver function tests in patients receiving parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 15: 54-59.
21. Clayton, P.T., Bowron, A., Mills, K.A., Massoud, A., Casteels, M., and Milla, P.J. 1993. Phytosterolemia in children with parenteral nutrition-asscoaited cholestatic liver disease. Gastroenterology, 105: 1806-13.
22. Ding, L.A., Li, J.S., Li, Y.S., Zhu, N.T., Liu, F.N., and Tan, L. 2004. Intestinal barrier damage caused by trauma and lipopolysaccharide. World J. Gastroenterol. 10: 2373-2378.
23. Drenick, E.J., Fisler, J., and Johnson, D. 1982. Hepatic steatosis after intestinal bypass-prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology, 82: 535-548.
24. Ellegard, L., Sunesson, A., and Bosaeus, I. 2005. High serum phytosterol levels in short bowel patients on parenteral nutrition support. Clin. Nutr. 24: 415-420. doi:10.1016/j.clnu.2005.01. 001.
25. Fouin-Fortunet, H., Le Quernec, L., Erlinger, S., Lerebours, E., and Colin, R. 1982. Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease: a possible consequence of lithocholate toxicity. Gastroenterology, 82: 932-937.
26. Fryer, J., Peller, S., Ormond, D., Koffron, A., and Abecassis, M. 2003. Mortality in candidates waiting for combine liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl. 9: 748-753. doi:10.1053/jlts.2003.50151.
27. Gonnella, P.A., Helton, W.S., Robinson, M., and Wilmore, D.W. 1992. O-side chain of Escherichia coli endotoxin 0111:B4 is transported across the intestinal epithelium in the rat: evidence of increased transport during total parenteral nutrition. Eur. J. Cell Biol. 59: 224-227.
28. Goplerud, J.M. 1992. Hyperalimentation associated hepatotoxicity in the newborn. Ann. Clin. Lab. Sci. 22: 79-84.
29. Gottschlich, M.M. 1992. Selection of optimal lipid sources in enteral and parenteral nutrition. Nutr. Clin. Pract. 7: 152-165.
30. Gura, K.M., Duggan, C.P., Collier, S.B., Jennings, R.W., Folkman, J., Bistrian, B.R., et al. 2006. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics, 118: e197-e201. doi:10.1542/peds.2005-2662.
31. Hellerstein, M.K., Schwartz, J.M., and Neese, R.A. 1996. Regulation of hepatic de novo lipogenesis in humans. Annu. Rev. Nutr. 16: 523-527.
32. Hofmann, A.F. 1995. Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions. J. Pediatr. Gastroenterol. Nutr. 20: 376-390.
33. Huxtable, R.J. 1992. Physiological actions of taurine. Physiol. Rev. 72: 101-163.
34. Hwang, T.L., Lue, M.C., and Chen, L.L. 2000. Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function. Hepatogastroenterology, 47: 1347-1350.
35. Iyer, K.R., Spitz, L., and Clayton, P. 1998. New insights into mechanisms of parenteral nutrition-associated cholestasis: Role of plant sterols. J. Pediatr. Surg. 33: 1-6. doi:10.1016/S0022-3468(98)90349-9.
36. Jawaheer, G., Pierro, A., Lloyd, D.A., and Shaw, NJ. 1995. Gall bladder contractility in neonates: effects of parenteral and enteral feeding. Arch. Dis. Child. Fetal Neonatal. Ed. 72: F200-F202.
37. Kaminski, D.L., Adams, A., and Jellinek, M. 1980. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery, 88: 93-100.
38. Kaufman, S.S., Atkinson, J.B., Bianchi, A., Goulet, O.J., Grant, D., Langnas, A.N., et al. 2001. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr. Transplant. 5: 80-87. doi:10.1034/j.1399-3046.2001.005002080.x.
39. Kelly, D.A. 1998. Liver complications of pediatric parenteral nutrition-epidemiology. Nutrition, 14: 153-157. doi:10.1016/S0899- 9007(97)00232-3.
40. Kumar, D., and Tandon, R.K. 2001. Use of ursodeoxycholic acid in liver diseases. J. Gastroenterol. Hepatol. 16: 3-14. doi:10.1046/j.1440-1746. 2001.02376.x.
41. Kwan, V., and George, J. 2004. Liver disease due to parenteral and enteral nutrition. Clin. Liver Dis. 8: 893-913. doi:10.1016/j.cld. 2004.06.003.
42. Labow, B.I., and Souba, W.W. 2000. Glutamine. World J. Surg. 24: 1503-1513. doi:10.1007/s002680010269.
43. Lambert, J.R., and Thomas, S.M. 1985. Metronidazole prevention of serum liver enzyme abnormalities during parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 9: 501-503.
44. Levine, A., Maayan, A., Shamir, R., Dinari, G., Sulkes, J., and Sirotta, L. 1999. Parenteral nutrition-associated cholestasis in pre-term neonates: evaluation of ursodeoxycholic acid treatment. J. Pediatr. Endocrinol. Metab. 12: 549-553.
45. Li, S., Nussbaum, M.S., Teague, D., Gapen, C.L., Dayal, R., and Fischer, J.E. 1988. Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagons in rat. J. Surg. Res. 44: 639-648. doi:10.1016/0022-4804(88) 90095-9.
46. Luman, W., and Shaffer, J.L. 2002. Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin. Nutr. 21: 337-343. doi:10.1054/clnu.2002.0554.
47. Matilla, B., Ortiz, J., Gonzalez, P., Garcia-Diez, F., Jorquera, F., Culebras, J.M., et al. 2000. Effects of parenteral nutrition supplemented with glutamine or glutamine dipeptides on liver antioxidant and detoxication systems in rats. Nutrition, 16: 125-128. doi:10.1016/S0899-9007(99)00265-8.
48. Mayer, K., Meyer, S., Reinholz-Muhly, M., Maus, U., Merfels, M., Lohmeyer, J., et al. 2003. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J. Immunol. 171: 4837-4843.
49. Meguid, M.M., Chen, T.Y., Yang, Z.J., Campos, A.C., Hitch, D.C., Gleason, J.R., et al. 1991. Effects of continuous graded total parenteral nutrition on feeding indexes and metabolic concomitants in rats. Am. J. Physiol. 260: E126-E140.
50. Messing, B. 2006. Guidelines for management of home parenteral support in adult chronic intestinal failute patients. Gastroenterology, 130 (Suppl 1): S43-S51. doi:10.1053/j.gastro.2005.09.064.
51. Messing, B., Bories, C., Kunstlinger, F., and Bernier, J.J. 1983. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology, 84: 1012-1019.
52. Messing, B., Lemann, M., Landais, P., Gouttebel, M.C., Gerard-Boncompain, M., Saudin, F., et al. 1995. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology, 108: 1005-1010. doi:10.1016/0016-5085(95)90196-5.
53. Nightingale, J.M. 2003. Hepatobiliary, renal and bone complications of intestinal failure. Best Pract. Res. Clin. Gastroenterol. 17: 907-929. doi:10.1016/S1521-6918(03)00108-2.
54. Oz, H.S., McClain, C.J., Nagasaw, H.T., Ray, M.B., de Villiers, W.J., and Chen, T.S. 2004. Diverse antioxidants protect against acetaminophen hepatoxicity. J. Biochem. Mol. Toxicol. 18: 361-368.
55. Oz, H.S., Im, H.J., Chen, T.S., de Villiers, W.J., and McClain, C.J. 2006. Glutathione-enhancing agents protect against steatohepatitis in a dietary model. J. Biochem. Mol. Toxicol. 20: 39-47. doi:10.1002/jbt.20109.
56. Payne-James, J.J., and Silk, D.B. 1991. Hepatobiliary dysfunction associated with total parenteral nutrition. Dig. Dis. 9: 106-124.
57. Pierro, A., van Saene, H.K., Donnell, S.C., Hughes, J., Ewan, C., Nunn, A.J., et al. 1996. Microbial translocation in neonates and infants receiving long-term parenteral nutrition. Arch. Surg. 131:176-179.
58. Porayko, M.K. 1998. Liver dysfunction and parenteral nutrition therapies. Clin. Liver Dis. 2: 133-147. doi:10.1016/S1089-3261(05)70368-8.
59. Powell, E.E., Cooksley, W.G., Hanson, R., Searle, J., Halliday, J.W., and Powell, L.W. 1990. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology, 11: 74-80. doi:10.1002/hep.1840110114.
60. Quigley, E.M., Marsh, M.N., Shaffer, J.L., and Markin, R.S. 1993. Hepatobiliary complications of total parenteral nutrition. Gastroenterology, 104: 286-301.
61. Reimund, J.M., Arondel, Y., Joly, F., Messing, B., Duclos, B., and Baumann, R. 2004. Potential usefulness of olive oil-based emulsions in selected situations of home parenteral nutrition-associated liver disease. Clin. Nutr. 23: 1418-1425. doi:10.1016/j.clnu.2004.08.011.
62. Rintala, R.J., Lindahl, H., and Pohjavuori, M. 1995. Total parenteral nutrition-associated cholestasis in surgical neonates may be reversed by intravenous cholcystokinin: a preliminary report. J. Pediatr. Surg. 30: 827-830. doi:10.1016/0022-3468(95)90758-0.
63. Roslyn, J.J., Pitt, H.A., Mann, L.L., Ament, M.E., and DenBesten, L. 1983. Gallbladder disease in patients on long term parenteral nutrition. Gastroenterology, 84: 148-154.
64. Rubin, M., Moser, A., Vaserberg, N., Greig, F., Levy, Y., Spivak, H., et al. 2000. Structured triacylglecerol emulsion, containing both medium and long chain fatty acids, in long-term home parenteral nutrition: a double blind randomized cross-over study. Nutrition, 16: 95-100. doi:10.1016/S0899- 9007(99)00249-X.
65. Sandhu, I.S., Jarvis, C., and Everson, G.T. 1999. Total parenteral nutrition and cholestasis. Clin. Liver Dis. 3: 489-508. doi:10.1016/S1089-3261(05)70082-9.
66. Schneider, S.M., Joly, F., Gehrardt, M.F., Badran, A.M., Myara, A., Thuillier, F., et al. 2006. Taurine status and response to intravenous taurine supplementation in adults with short bowel syndrome undergoing long-term paretneral nutrition: a pilot study. Br. J. Nutr. 96: 365-370. doi:10.1079/BJN20061826.
67. Sinha, S., Perdomo, G., Brown, N.F., and O'Doherty, R.M. 2004. Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B. J. Biol. Chem. 279: 41294-41301. doi:10.1074/jbc.M406514200.
68. Sokol, R.J., Taylor, S.F., Devereaux, M.W., Khandwala, R., Sondheimer, N.J., Shikes, R.H., et al. 1996. Hepatic oxidant injury and glutathione depletion during total parenteral nutrition in weanling rats. Am. J. Physiol. 270: G691-G700.
69. Spagnuolo, M.I., Iorio, R., Vegnente, A., and Guarino, A. 1996. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology, 111: 716-719. doi:10.1053/gast.1996.v111.pm8780577.
70. Teitelbaum, D.H., Han-Markey, T., and Schumacher, R.E. 1995. Treatment of parenteral nutrition associated cholestasis with cholecystokinin-octapeptide. J. Pediatr. Surg. 30: 1082-1085. doi:10.1016/0022-3468(95)90346-1.
71. Trauner, M., Wagner, M., Fickert, P., and Zollner, G. 2005. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J. Clin. Gastroenterol. 39 (Suppl 2): S111-S124. doi:10.1097/01.mcg.0000155551.37266.26.
72. Werner, A., Havinga, R., Bos, T., Bloks, V.W., Kuipers, F., and Verkade, H.J. 2005. Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particles. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G1150-G1158. doi:10.1152/ajpgi.00456.2004.
73. Wolfe, R.R., O'Donnell, T.F., Stone, M.D., Richmand, D.A., and Burke, J.F. 1980. Investigation of factors determining the optimal glucose infusion rate in total parenteral nutrition. Metabolism, 29: 892-900. doi:10.1016/0026-0495(80)90130-4.
74. Wu, J., Hong, L., Cai, W., Tang, Q., and Shi, C. 2007. Glutamine attenuates TPN associated liver injury in infant rabbits. Eur. J. Pediatr. 166: 601-606. doi:10.1007/s00431-006-0294-x.
75. Yao, Z., and McLeod, R.S. 1994. Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins. Biochim. Biophys. Acta, 1212: 152-166.
76. Zaman, N., Tam, Y.K., Jewell, L.D., and Coutts, R.T. 1997. Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm. Drug Dispos. 18: 803-819. doi:10.1002/(SICI)1099- 081X(199712)18:9〈803::AID-BDD65〉3.0.CO;2-S.
77. Zamir, O., Nussbaum, M.S., Bhadra, S., Subbiah, M.T., Rafferty, J.F., and Fischer, J.E. 1994. Effect of enteral feeding on hepatic steatosis induced by total parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 18: 20-25.